Dune Medical Devices has designed a reposable version of its MarginProbe radiofrequency spectropscopy device, which can help surgeons identify remaining cancer cells in real time during a lumpectomy. The updated MarginProbe has a reusable cable and handle and a single-use attachable probe. It has the potential to reduce waste burden of the MarginProbe up to […]
OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]
Dune Medical Devices said today it is relocating its US headquarters to Alpharetta, Ga., near Atlanta, from Paoli, Penn. as the company looks to expand its portfolio and improve uptake and reimbursement for its MarginProbe device. The MarginProbe is a breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries, the […]
Dune Medical Devices said today that it raised another $12 million it plans to use to expand the indications for the radiofrequency spectroscopy technology used in its MarginProbe cancer detection device. Alpharetta, Ga.- and Caesarea, Israel-based Dune said the $12.3 million round was led by Canepa Healthcare, ATON Partners and the Kraft Group. Dune said it plans […]
Titan Medical CEO Hargrove is out Titan Medical (CVE:TMD) said today that it’s looking for a new CEO after the resignation of John Hargrove as it looks to get back on track with the development program for its Sport robot-assisted surgery platform. Toronto-based Titan said board member John Barker is slated to fill Hargrove’s shoes on […]
Dune Medical Devices said today it won a $3.4 million (EU €3 million) European Union Horizon 2020 research grant. The company said it is 1 of 65 companies selected to receive funding from the $91 billion (EU €80 billion) 7-year program aiming to “secure Europe’s global competitiveness.” “This 3 million euro grant will expedite bringing our […]
Dune Medical Devices said this week that the U.K.’s National Health Service is launching a study of its MarginProbe device, which is designed to spot cancerous cells on the margins of breast tumors. Paoli, Pa.-based Dune said the NHS’s National Institute of Health Research arm is funding a study to see whether MarginProbe reduces the need for further re-excision […]
Dune Medical Devices said today it won pre-market approval from the FDA for modifications to its MarginProbe breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries. Modifications to the Paoli, Penn.-based company’s device were made to conform to recent changes in the European Union’s Restriction of Hazardous Substances requirements, Dune […]
Fonar Corp (NSDQ:FONR) said yesterday it named Timothy Damadian, son of magnetic resonance scanning inventor and company founder Dr. Raymond Damadian, as its new president and CEO. The younger Damadian worked with Fonar for 16 years, eventually becoming veep of operations. He formed Fonar subsidiary Health Management Corporation of America, which manages medial and diagnostic […]
Israeli imaging systems maker Dune Medical Devices touted the successful raise of $14 million in equity financing, looking to secure another $7 million before October to support its commercialization efforts.
Dune Medical Devices won European regulatory approval for the latest generation of its breast cancer detection tool, the MarginProbe System Type 1.2 console.